ABSTRACT
Precautionary allergen labelling (PAL) was introduced by the food industry to help manage and communicate the possibility of reaction from the unintended presence of allergens in foods. However, in its current form, PAL is counterproductive for consumers with food allergies. This review aims to summarize the perspectives of all the key stakeholders (including clinicians, patients, food industry and regulators), with the aim of defining common health protection and risk minimization goals. The lack of agreed reference doses has resulted in inconsistent application of PAL by the food industry and in levels of contamination that prompt withdrawal action by enforcement officers. So there is a poor relationship between the presence or absence of PAL and actual reaction risk. This has led to a loss of trust in PAL, reducing the ability of consumers with food allergies to make informed choices. The result has been reduced avoidance, reduced quality of life and increased risk-taking by consumers who often ignore PAL. All contributing stakeholders agree that PAL must reflect actual risk. PAL should be transparent and consistent with rules underpinning decision-making process being communicated clearly to all stakeholders. The use of PAL should indicate the possible, unintended presence of an allergen in a consumed portion of a food product at or above any proposed action level. This will require combined work by all stakeholders to ensure everyone understands the approach and its limitations. Consumers with food allergy then need to be educated to undertake individualized risk assessments in relation to any PAL present.
Subject(s)
Allergens , Food Labeling/standards , Food Hypersensitivity/prevention & control , Food Industry , Health Personnel , Humans , Risk AssessmentSubject(s)
Edible Grain/chemistry , Food Handling , Mycotoxins , Ochratoxins/analysis , Drug Stability , Food ContaminationABSTRACT
The influence of dietary caffeine on the genotoxicity of the cooked food mutagen 2-amino-3,8-dimethylimidazo[4,5-f]-quinoxaline (MeIQx) was evaluated using the host-mediated assay in mice. For four weeks, BALB/c mice were fed a purified diet with or without caffeine (0.01% wt/wt in the diet). In the host-mediated assay, Salmonella typhimurium TA98 was given intravenously immediately before an oral dose of MeIQx (1.5 mg/kg body wt). After one hour, the mice were killed, the Salmonellae were recovered from the liver, and the number of mutants (his+ revertants) were determined. Consumption of caffeine led to a 47% reduction in the number of mutants induced by MeIQx (p < 0.001). Subsequent in vitro experiments using S. typhimurium TA98 revealed that the capacity of hepatic S-9 fractions from the caffeine-fed mice to covert MeIQx to an active mutagen was reduced by approximately 35%. This effect was not attributable to caffeine in the S-9 preparation. These data suggest that consumption of caffeine modifies MeIQx mutagenicity by altering the spectrum of enzymes involved in its activation.
Subject(s)
Caffeine/pharmacology , Carcinogens/antagonists & inhibitors , Diet , Quinoxalines/antagonists & inhibitors , Animals , Caffeine/administration & dosage , Carcinogens/adverse effects , Cytochrome P-450 Enzyme System/analysis , Dose-Response Relationship, Drug , Drug Interactions , Female , Liver/drug effects , Liver/enzymology , Mice , Mice, Inbred BALB C , Quinoxalines/pharmacology , Salmonella typhimuriumABSTRACT
Coal tar, a tumour initiator, and dithranol, a tumour promoter, are used in the treatment of psoriasis. Topical treatment of mice with pharmaceutical formulations of these two agents, at therapeutic doses, induced skin papillomas in a classical two-stage carcinogenesis protocol, while treatment with either agent alone did not. This finding has implications for the use of both agents in combination in the treatment of psoriasis.
Subject(s)
Anthralin/toxicity , Carcinogens/toxicity , Coal Tar/toxicity , Psoriasis/drug therapy , Skin Neoplasms/chemically induced , Adenosine Triphosphate/metabolism , Administration, Topical , Animals , Anthralin/administration & dosage , Benzo(a)pyrene/toxicity , Carcinogens/administration & dosage , Coal Tar/administration & dosage , DNA/biosynthesis , DNA, Neoplasm/biosynthesis , Female , Mice , Ointments , Phosphorus Radioisotopes , Skin Neoplasms/pathologyABSTRACT
Female BALB/c mice were fed either a low (1%)-fat or one of three high-fat diets (containing an additional 25% (w/w) beef fat, hydrogenated vegetable oil or non-hydrogenated vegetable oil) for 4 wk. They were then orally treated with 10 mg 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)/kg body weight and killed 6 hr later. Consumption of the hydrogenated vegetable oil was accompanied by increased DNA adduct formation in mice. The abilities of hepatic S-9 preparations from mice fed the various diets to convert MeIQx to an active bacterial mutagen was assessed using Salmonella typhimurium TA98. Preparations from mice fed the high-fat diets exhibited significantly greater capacity to activate MeIQx than did those from low-fat-fed mice. The greatest increases were seen with S-9 from animals fed either beef fat or hydrogenated vegetable oil.
Subject(s)
DNA/metabolism , Dietary Fats/pharmacology , Liver/drug effects , Liver/metabolism , Mutagens/metabolism , Quinoxalines/metabolism , Administration, Oral , Animals , Female , Mice , Mice, Inbred BALB C , Mutagenicity Tests , Mutagens/toxicity , Quinoxalines/toxicityABSTRACT
The effect of arachidonic acid, eicosapentaenoic acid and docosahexaenoic acid on the conversion of the heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) to its genotoxic metabolites was investigated using a modified bacterial mutation assay. The assay used Salmonella typhimurium TA98 as an indicator of the mutagenicity and hepatic post-mitochondrial fractions (S-9) from male Sprague-Dawley rats as the activating system. All three fatty acids inhibited the mutagenicity of IQ without effect on the uptake of the active metabolites and/or on the DNA repair processes within the bacterial cell. The activation of three other food mutagens, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and aflatoxin B1 (AFB1) was also inhibited by these fatty acids.
Subject(s)
Arachidonic Acid/pharmacology , Docosahexaenoic Acids/pharmacology , Eicosapentaenoic Acid/pharmacology , Food Contamination , Microsomes, Liver/metabolism , Mutagens/pharmacokinetics , Animals , Biotransformation , DNA Repair/drug effects , In Vitro Techniques , Male , Mutagenicity Tests , Quinolines/pharmacokinetics , Rats , Rats, Sprague-Dawley , Salmonella typhimurium/drug effects , Salmonella typhimurium/geneticsABSTRACT
Hepatic microsomal fractions (microsomes) were prepared from male Sprague-Dawley rats. The effect of arachidonic acid on the conversion of the heterocyclic aromatic amine 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) to its genotoxic metabolites was investigated using a modified bacterial mutation assay (indicator: Salmonella typhimurium TA98). Arachidonic acid inhibited the mutagenicity of IQ without effect on the uptake of the active metabolites and/or on the DNA-repair processes within the bacterial cell. The activation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and aflatoxin B1 (AFB1) was also inhibited by this polyunsaturated fatty acid.
Subject(s)
Antimutagenic Agents/pharmacology , Arachidonic Acid/pharmacology , Microsomes, Liver/metabolism , Mutagens/metabolism , Aflatoxin B1/metabolism , Aflatoxin B1/pharmacology , Animals , Biotransformation , DNA Repair , Food , Imidazoles/metabolism , Imidazoles/pharmacology , Male , Microsomes, Liver/drug effects , Mutagenicity Tests , Mutagens/pharmacology , Quinolines/metabolism , Quinolines/pharmacology , Quinoxalines/metabolism , Quinoxalines/pharmacology , Rats , Rats, Sprague-Dawley , Salmonella typhimurium/drug effectsABSTRACT
Intraperitoneal treatment of female BALB/c mice with either phenobarbitone or beta-naphthoflavone led to the induction of various hepatic enzymes associated with xenobiotic metabolism and to increased abilities of hepatic S9 fractions to convert the dietary carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) to an active bacterial mutagen. In the case of another carcinogen, aflatoxin B1 an increase in in vitro hepatic activation was seen only in mice treated with phenobarbitone. In contrast, pretreatment with either phenobarbitone or beta-naphthoflavone reduced the in vivo activity of both aflatoxin B1 and MeIQx in the host mediated bacterial mutation assay. These data indicate that, for some carcinogens at least, the host-mediated assay may be used to predict the carcinogenic consequences of hepatic enzyme induction.
Subject(s)
Aflatoxins/metabolism , Carcinogens/metabolism , Cytochrome P-450 Enzyme System/metabolism , Mutagens/metabolism , Quinoxalines/metabolism , Analysis of Variance , Animals , Benzoflavones/metabolism , Enzyme Induction , Female , Liver/enzymology , Mice , Mice, Inbred BALB C , Mutagenesis , Mutagenicity Tests/methods , Phenobarbital/metabolism , Salmonella typhimurium , beta-NaphthoflavoneABSTRACT
Female BALB/c mice were fed a low fat diet (1% safflower oil, by weight) or one supplemented with 25% (by weight) of beef fat or olive oil. The abilities of these diets to modify the in vitro and in vivo hepatic conversion of the dietary carcinogens aflatoxin B1, 2-amino-3, 4-dimethylimidazo[4,5-f]quinoline (MeIQ) and 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2) to bacterial mutagens was evaluated. Dietary olive oil appeared to increase the metabolism of both MeIQ and Trp-P-2 to bacterial mutagens in vivo using the intrasanguineous host-mediated assay. Feeding mice either of the high-fat diets increased hepatic conversion of these two compounds to bacterial mutagens in vitro. Dietary fat had no effect on the metabolism of aflatoxin B1. Subsequent experiments suggested that the in vivo effects of dietary olive oil on MeIQ and Trp-P-2 mutagenesis were due to the induction of hepatic enzyme activities rather than to increased rates of uptake of the carcinogen from the gut-lumen.
Subject(s)
Aflatoxins/toxicity , Carbolines/toxicity , Carcinogens/toxicity , Dietary Fats/administration & dosage , Quinolines/toxicity , Aflatoxin B1 , Aflatoxins/metabolism , Animals , Carbolines/metabolism , Carcinogens/metabolism , Female , Intestine, Small/metabolism , Liver/anatomy & histology , Mice , Mice, Inbred BALB C , Mutagenicity Tests , Mutagens , Organ Size , Quinolines/metabolismABSTRACT
The abilities of dietary fibre (wheat bran) or fat (olive oil) to modify the genotoxicity of radiolabelled MeIQ were evaluated in mice using in vivo and in vitro bacterial mutation assays. Bran reduced genotoxicity by restricting uptake of MeIQ from the gut lumen. In contrast, feeding mice a high fat diet led to increased hepatic conversion of MeIQ to an active genotoxin.
Subject(s)
Dietary Fats/pharmacology , Dietary Fiber/pharmacology , Mutagens/metabolism , Quinolines/metabolism , Animals , Female , Mice , Mice, Inbred BALB C , Mutagenicity Tests , Mutagens/antagonists & inhibitors , Quinolines/antagonists & inhibitors , Quinolines/toxicity , Salmonella typhimurium/drug effectsABSTRACT
Female BALB/c mice were fed diets containing equimolar amounts of quercetin or its glycoside, rutin, for 5 weeks. These mice were used either in host-mediated bacterial mutation assays or as sources of hepatic microsomes. In host-mediated bacterial mutation assays using radiolabelled mutagens, the heterocyclic amines 2-amino-3,5-dimethyl[4,5-f]imidazoquinoline (MeIQ) and 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2) induced greater numbers of revertants in mice fed either of the flavonoid diets compared with control. Experiments using hepatic microsomes revealed that although feeding mice either flavonoid produced slight changes in some parameters of hepatic xenobiotic metabolism (mixed function oxidase and glutathione transferase activities), microsomes from quercetin-fed mice were more potent activators of both MeIQ and Trp-P-2 compared with microsomes from control or rutin-fed mice. This difference in microsomal ability may be due to the different biological availability of the two flavonoids within the gastrointestinal tract.
Subject(s)
Flavonoids/pharmacology , Quercetin/pharmacology , Quinolines/toxicity , Animals , Carbolines/toxicity , DNA Damage , Diet , Female , Kinetics , Mice , Mice, Inbred BALB C , Microsomes, Liver/drug effects , Microsomes, Liver/metabolism , Mutagenicity Tests , Mutagens , Quinolines/antagonists & inhibitors , Rutin/pharmacology , XenobioticsABSTRACT
Female BALB/c mice were administered intragastrically with equimolar amounts of either [2-14C]2-amino-3,8-dimethyl-[4,5-f]quinoxaline (MeIQx) or 2-acetylamino[9-14C]fluorene (2AAF). DNA was isolated from tissues of mice killed either 6 or 24 h after administration. Analysis of lvier DNA nucleotide digests by HPLC analysis revealed that all of the radioactivity was attributable to adduct formation. The specific activities of DNA samples were converted to covalent binding indices (CBI, mumol adduct per mol DNA nucleotides/mmol chemical applied per kg animal body weight). CBI values of 25 and 9 were determined for 2AAF and MeIQx in the livers of mice killed 6 h after dosing. The values were in general agreement with the moderate carcinogenic potency of these compounds. The specific activities of DNA preparations obtained from the kidneys, spleens, stomachs, small intestines and large intestines of mice treated with MeIQx and killed 6 h after dosing were 5- to 35-times less than those obtained with the liver. DNA isolated from the lungs (a target organ for MeIQx tumorigenicity) of MeIQx-treated mice was not radiolabelled at the limit of detection (CBI less than 0.3). With the exception of the gastrointestinal tract, the specific activities of DNA samples isolated from mice killed 6 h after administration were higher than those from mice killed after 24 h.
Subject(s)
DNA/metabolism , Mutagens/metabolism , Quinoxalines/metabolism , Animals , Carbon Radioisotopes , Chromatography, High Pressure Liquid , DNA/isolation & purification , Female , Kinetics , Mice , Mice, Inbred BALB C , Quinoxalines/pharmacokinetics , Radioisotope Dilution Technique , Tissue DistributionABSTRACT
Female BALB/c mice were fed either a fibre-free diet or one supplemented with 30% wheat-bran for 5 weeks. The ability of these mice to convert MeIQ to a bacterial mutagen in vivo was determined using intrasanguinous host-mediated bacterial mutation assays. Less mutagenic activity was detected in the livers of mice fed the bran-supplemented diet compared with those fed the fibre-free diet. Subsequent experiments demonstrated that the effect of brain was not due to modifications in hepatic metabolism, but to changes in uptake of MeIQ from the gastrointestinal tract.
Subject(s)
Dietary Fiber/physiology , Mutation/drug effects , Quinolines/pharmacokinetics , Administration, Oral , Animals , Biotransformation , Gastric Mucosa/metabolism , Intestinal Absorption , Intestine, Small/metabolism , Liver/metabolism , Mice , Mice, Inbred BALB C , Microsomes, Liver/metabolism , Quinolines/toxicity , Tissue Distribution , TriticumABSTRACT
The kinetics of distribution of radiolabelled [2-14C]IQ (2-amino-3-methylimidazo[4,5-f]quinoline) and [2-14C]MeIQx (2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline) following the oral administration to BALB/c mice of single doses were studied. Both compounds were taken up into the blood-stream and other tissues rapidly after administration and approximately 20-25% of the radioactive dose of IQ or MeIQx was excreted in urine over 6 h, reflecting the rapid absorption of the mutagens. Significantly greater levels of MeIQx than IQ were isolated from the lungs and blood of treated mice. In studies of the uptake of IQ from closed sections of the gut, little IQ was absorbed from the stomach. Although there was some evidence that it could be absorbed from the large intestine, the primary site of IQ absorption was the small intestine.
Subject(s)
Carcinogens/pharmacokinetics , Quinolines/pharmacokinetics , Quinoxalines/pharmacokinetics , Administration, Oral , Animals , Carbon Radioisotopes , Carcinogens/urine , Chromatography, Thin Layer , Female , Gastrointestinal Contents/analysis , Intestinal Absorption , Mice , Mice, Inbred BALB C , Quinolines/urine , Quinoxalines/urine , Tissue DistributionABSTRACT
Hepatic microsomal fractions (microsomes) were prepared from female BALB/c mice. The potential of caffeine to modify the ability of microsomes to convert the heterocyclic aromatic amines MeIQ, Trp-P-2 and MeIQx, to bacterial mutagens (indicator: Salmonella typhimurium TA98) was investigated. Caffeine inhibited mutagenicity and did so by inhibiting microsomal metabolism of the three compounds, rather than by altering uptake of the active mutagens and/or interacting with the DNA repair processes in the bacterial cell. Notional Ki values determined for the three heterocyclic amines were similar, suggesting that caffeine inhibits at a stage common to the metabolism of all three compounds.
Subject(s)
Caffeine/pharmacology , Microsomes, Liver/metabolism , Mutagens/metabolism , Animals , Biotransformation , Dose-Response Relationship, Drug , Female , Mice , Mice, Inbred BALB C , Microsomes, Liver/drug effects , Mutagenicity Tests , Mutagens/pharmacology , Reference Values , Salmonella typhimurium/drug effectsSubject(s)
Cytochrome P-450 Enzyme System/metabolism , Flavonoids/pharmacology , Intestines/microbiology , Liver/enzymology , Mixed Function Oxygenases/metabolism , Quercetin/pharmacology , Rutin/pharmacology , Animals , Diet , Female , Liver/drug effects , Mice , Mice, Inbred BALB C , Microsomes, Liver/enzymologyABSTRACT
The biogenic amines tryptamine, 5-hydroxytryptamine, tyramine and histamine were assessed for their abilities to modify the genotoxicity of the cooked-food mutagens IQ, MeIQ, MeIQx, Trp-P-1 and Trp-P-2. These measurements were made using a bacterial mutation assay with hepatic fractions from either SWR mice or DSN Syrian hamsters as the activating system and Salmonella typhimurium TA98 as the indicator organism. Although histamine had very little effect on the genotoxicity of these mutagens, the other amines reduced genotoxicity, with tryptamine and 5-hydroxytryptamine exerting the greatest effect. Generally the amines exhibited greater potency when S-9 fractions from mice rather than from hamsters were used.
Subject(s)
Biogenic Amines/pharmacology , Food , Mutagens/antagonists & inhibitors , Animals , Biotransformation , Cooking , Cricetinae , Histamine/pharmacology , Male , Mesocricetus , Mice , Mutagenicity Tests , Mutagens/metabolism , Serotonin/pharmacology , Species Specificity , Tryptamines/pharmacology , Tyramine/pharmacologyABSTRACT
Male Ola:Sprague-Dawley rats were fed diets containing either low or high levels of fats. After being fed these diets for 4 weeks, the rats were killed and individual hepatic postmitochondrial (S9) fractions were prepared. The ability of these fractions to convert the heterocyclic aromatic amines (HAAs)--2-amino-3-methylimidazo[4,5-f]quinoline; 2-amino-3,4-dimethylimidazo[4,5-f] quinoline; and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (compounds produced during the cooking of proteinaceous food)--to bacterial mutagens was studied, with the use of Salmonella typhimurium TA98 as indicator. Fractions from rats fed high-fat diets exhibited a greater ability to activate the HAAs than did those from rats fed the low-fat diet. The magnitude of the increase was dependent on the type of fat used.
Subject(s)
Dietary Fats/administration & dosage , Mitochondria, Liver/metabolism , Mutagens/toxicity , Animals , Aroclors/pharmacology , Biotransformation , Dietary Fats/pharmacology , Male , Mutagenicity Tests , Rats , Rats, Inbred StrainsABSTRACT
Groups of Sprague-Dawley rats were fed on diets containing increasing amounts of beef dripping, but having a constant cholesterol content. One group of rats was fed on a diet containing no dripping and no added cholesterol (control). We have studied the ability of individual hepatic S9 preparations to activate the cooked food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQX) to bacterial mutagens using Salmonella typhimurium TA98 as indicator. Hepatic preparations from animals fed on a high cholesterol, low-fat diet were less effective in activating the mutagens than preparations from rats fed on the control diet. It was also observed that the capacity of hepatic preparations to activate these mutagens increased as the amount of dripping in the diet increased. These results suggest that it is the triglyceride rather than the cholesterol content of beef dripping which promotes increased mutagen activation capacity in the liver.
Subject(s)
Cholesterol, Dietary/pharmacology , Dietary Fats/pharmacology , Microsomes, Liver/metabolism , Mutagens/pharmacology , Mutation , Quinolines/pharmacology , Quinoxalines/pharmacology , Animals , Biotransformation , Cattle , Hot Temperature , Male , Mutagenicity Tests , Mutagens/metabolism , Quinolines/metabolism , Quinoxalines/metabolism , Rats , Rats, Inbred Strains , Salmonella typhimurium/drug effectsABSTRACT
A method of maintaining the microflora obtained from the hypochlorhydric stomach of a patient suffering from hypogammaglobulinaemia has been developed using continuous culture (chemostat) techniques. The culture was maintained at pH 8.0 (the pH of the original gastric juice) and subsequently at pH 7.0 and pH 6.0. Throughout the experiment the total population of the culture remained constant, although the populations of individual bacterial strains varied. Two enzyme parameters, nitrate reductase and beta-glycosidase, were also measured. Optimal enzyme activity was observed at pH 7.0. The results suggest that at the physiological pH values found in hypochlorhydric patients, the gastric flora may play a role in the generation of genotoxins and/or their precursors.